Literature DB >> 22330089

Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.

Yu-Y Chang1, J-K Lin, J-K Jiang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330089     DOI: 10.1111/j.1463-1318.2012.02986.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


× No keyword cloud information.
  5 in total

Review 1.  Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism.

Authors:  Michel Tchan
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

2.  Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy.

Authors:  Hee Jung Yi; Kyung Sook Hong; Nara Moon; Soon Sup Chung; Ryung-Ah Lee; Kwang Ho Kim
Journal:  Ann Surg Treat Res       Date:  2016-02-26       Impact factor: 1.859

3.  Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.

Authors:  J Lazier; S M Lupichuk; I Sosova; A A Khan
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

4.  Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report.

Authors:  Takatsugu Ogata; Hironaga Satake; Misato Ogata; Yukimasa Hatachi; Hisateru Yasui
Journal:  Case Rep Oncol       Date:  2017-10-10

Review 5.  Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.

Authors:  Seiichiro Mitani; Shigenori Kadowaki; Azusa Komori; Keiji Sugiyama; Yukiya Narita; Hiroya Taniguchi; Takashi Ura; Masashi Ando; Yozo Sato; Hidekazu Yamaura; Yoshitaka Inaba; Makoto Ishihara; Tsutomu Tanaka; Masahiro Tajika; Kei Muro
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.